Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.40 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Big-h3 via down regualtion of its target gene, 16/April/2014, 6.38 am
April 16, 2014
Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, decreases the expression of Interleukin-2 via down regulation of its target gene, 16/April/2014, 6.45 am
April 16, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK  via  down regulation of  its target gene, 16/April/2014, 6.41 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.